Louie Ngar Yee - Dec 30, 2022 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Director
Signature
/s/ Louie Ngar Yee
Stock symbol
MAIA
Transactions as of
Dec 30, 2022
Transactions value $
$0
Form type
4
Date filed
1/4/2023, 05:18 PM
Previous filing
Aug 2, 2022
Next filing
Apr 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAIA Stock Options Award $0 +4.57K $0.00 4.57K Dec 30, 2022 Common Stock 4.57K $3.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options, granted on December 30, 2022 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.